Shaping the future of precision oncology
From diagnosis through survivorship, supporting patients across the continuum of care.
From detection to decision-making
Featured research across the continuum of care, from diagnosis through survivorship.
Precision oncology portfolio
Natera's oncology portfolio is future-ready
Only Natera combines market-leading MRD technologies — including Genome across tumor types and tfMRD — with treatment-selection assays Altera™, Empower™, and AI-powered real-world data tools, to deliver a comprehensive precision oncology platform.
Platform capabilities
TOMR
Multiple abstracts explore MRD-guided decision-making and its impact on patient and treatment selection.
Pan-cancer MRD
A pan-cancer MRD meta-analysis assessing performance across multiple histologies in the adjuvant and surveillance settings.
Phased variant tech
Analyses on the performance of Natera's ultra-sensitive phased variant technology, focusing on lung cancer and lymphoma.
Real-world data
Multiple datasets showcase Natera's RWD capabilities, including a pan-cancer analysis of ~245K patients.
Introducing Annotation for enriched clinical journeys
Annotation transforms black-and-white longitudinal reports into clinical context — molecular results layered with diagnosis, surgery, and therapy response.
Unified clinical context
Layer multi-modal information for unified clinical context.
Built for tumor boards
Export graphical summaries to inform multidisciplinary discussions and institutional research.
Clearer patient counseling
Enhance patient counseling with personalized visual trends.
Priority cases
Identify high-priority Signatera™ positive cases.
Connect with Natera at meetings featuring ASCO highlights
-
JUN12Binaytara 2026 Seattle Best of Oncology™ Seattle · 2026Register
-
JUN132026 Best of ASCO® Austin Austin · 2026Register
-
JUN14Best of ASCO® Los Angeles Los Angeles · 2026Register
-
JUN19Binaytara 2026 Portland Best of Oncology™ Portland · 2026Register
-
JUN26Binaytara 2026 El Paso Best of Oncology™ El Paso · 2026Register
-
JUN27Binaytara 2026 Boise Best of Oncology™ Boise · 2026Register
-
JUN272026 Best of ASCO® Honolulu Honolulu · 2026Register
-
JUN272026 Best of ASCO® Washington DC Washington DC · 2026Register
-
JUL10Binaytara 2026 Shreveport Best of Oncology™ Shreveport · 2026Register
-
JUL102026 Best of ASCO® Long Island Long Island · 2026Register
-
JUL112026 Best of ASCO® Dallas Dallas · 2026Register
-
JUL17Binaytara 2026 Omaha Best of Oncology™ Omaha · 2026Register
-
JUL182026 Best of ASCO® Philadelphia Philadelphia · 2026Register
-
JUL182026 Best of ASCO® Anchorage Anchorage · 2026Register
-
JUL182026 Best of ASCO® Charlotte Charlotte · 2026Register
-
JUL18Best of ASCO® Scottsdale Scottsdale · 2026Register
-
JUL252026 Best of ASCO® Las Vegas Las Vegas · 2026Register
-
JUL252026 Best of ASCO® Indianapolis Indianapolis · 2026Register
-
JUL252026 Best of ASCO® Seattle Seattle · 2026Register
-
JUL31Best of ASCO® Miami Miami · 2026Register
-
AUG12026 Best of ASCO® Minneapolis Minneapolis · 2026Register
-
AUG12026 Best of ASCO® Maine Maine · 2026Register
-
AUG12026 Best of ASCO® Pittsburgh Pittsburgh · 2026Register
-
AUG82026 Best of ASCO® Portland Portland · 2026Register
-
AUG82026 Best of ASCO® Boston Boston · 2026Register
-
AUG82026 Best of ASCO® Memphis Memphis · 2026Register
-
AUG14Binaytara 2026 Albuquerque Best of Oncology™ Albuquerque · 2026Register
-
AUG152026 Oncology Clinical Updates — Review and Renew 2026Register
-
AUG21GASCO's 2026 Annual Meeting and Best of ASCO® 2026Register
-
SEP122026 Best of ASCO® West Texas West Texas · 2026Register
Connect with our team
Personalized testing can help answer important questions after a cancer diagnosis. Tell us a bit about you and a member of our team will follow up.